DMAA (Tag Archives)
Subscribe to PricePlow's Newsletter and DMAA Alerts
Glaxon Founder Michael Bischoff Indicted and Prosecuted on Misbranded Drug Charge
On April 25, 2023, Glaxon Founder and CEO Michael Bischoff was indicted on a misbranded drug charge stemming from activities of his company, G.B. Nutrition,[1] and on August 21, 2023, Bischoff pleaded guilty.[2]
This news has come as a surprise to us and, we expect, to nearly everyone in the dietary supplement space. Even […]
Continue Reading →
Dan Fabricant (NPA): Why You Need to Show Up in Washington DC | Episode #100
https://blog.priceplow.com/podcast/dan-fabricant-npa-2023-washington-dc
For Episode 100 of the PricePlow Podcast, Ben and Mike flew to Washington D.C. for the Natural Products Association’s annual DC Fly-In Day on June 7, 2023. Fly-in days, also known as “lobby days”, bring individuals together to advocate with legislators and other officials on behalf of their shared interests.
So this was […]
Continue Reading →
Melatonin and CBD Under Fire? Meet Pieter Cohen, the Grim Reaper of ‘Gray Area’ Ingredients
The Journal of the American Medicine Association (JAMA) recently published a study showing that the quality control on melatonin gummies in the United States may not be the best – unfortunately, only 12% of the products tested were FDA compliant.[1]
Reason being, the FDA generally allows a discrepancy of up to 10% between a product’s […]
Continue Reading →
DMAA Banned From Supplements: Hi-Tech Pharmaceuticals Loses Appeal
Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.
This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow take this to the Supreme Court, which seems unlikely given the current political climate.
On August […]
Continue Reading →
Government Ordered to Return Five Truckloads of DMAA to Hi-Tech Pharma
All has been quiet on the DMAA front, pending Hi-Tech’s DMAA Lawsuit Appeal to the 11th Circuit, a decision we’re still waiting on after oral arguments were heard in August 2018.
We finally have a bit of an update, but it’s important to stress that Hi-Tech is still under an order from Judge Alan Braverman […]
Continue Reading →
DMAA FDA Lawsuit Appeal Oral Arguments: Hi-Tech Gets Their Day in Court
In March of 2018, we were left with Hi-Tech Pharmaceuticals’ appeal to the Eleventh Circuit court over their DMAA lawsuit against the FDA. Before we get into the update, a quick recap:
Hi-Tech appealed the ruling of district court judge Willis B. Hunt because he made his decision against them based upon information that neither[…]
Continue Reading →
Hi-Tech’s FDA DMAA Lawsuit Recap (Updated April 2020)
Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.
This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow take this to the Supreme Court, which seems unlikely given the current political climate.
BREAKING (August […]
Continue Reading →
Hi-Tech Fights to Get its Confiscated DMAA Back (December 2017)
Update May 3, 2019: A judge ordered the US Government to return Hi-Tech’s seized DMAA (see “Government Ordered to Return Five Truckloads of DMAA to Hi-Tech Pharma“), but it was ultimately for naught since Hi-Tech Lost the DMAA case.
Update December 28, 2017: Hi-Tech Pharmaceuticals has appealed the Magistrate Judge’s decision denying their request to […]
Continue Reading →
Hi-Tech Pharmaceuticals Raided… Over RED YEAST RICE??
November 15, 2017 Update: Hi-Tech has filed a motion to amend the terms agreed to in this indictment (ie. they’re fighting […]
Continue Reading →
Is Angelo Lisi’s Geranium Study the WEAKEST Study Ever Published?
This is part five of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.
In our previous article, we explored how the FDA wasted $2.3 million dollars on a study where researchers Mahmoud […]
Continue Reading →
